We have also previously shown that MBZ induces an M1 phenotype in human macrophage models and potentiates the anti-cancer activity of CD3/IL-2 activated peripheral blood mononuclear cells (PBMCs), the effect being attenuated by removal of CD14+ myeloid cells38. The gene discussed is IL2; the disease is cancer.